SELLAS Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. 

CEO
Angelos M. Stergiou
CEOAngelos M. Stergiou
Employees
15
Employees15
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2006
Founded2006
Employees
15
Employees15

SLS Key Statistics

Market cap
297.26M
Market cap297.26M
Price-Earnings ratio
-7.08
Price-Earnings ratio-7.08
Dividend yield
Dividend yield
Average volume
5.86M
Average volume5.86M
High today
$2.12
High today$2.12
Low today
$1.99
Low today$1.99
Open price
$2.04
Open price$2.04
Volume
5.73M
Volume5.73M
52 Week high
$2.48
52 Week high$2.48
52 Week low
$0.772
52 Week low$0.772

Stock Snapshot

With a market cap of 297.26M, SELLAS Life Sciences(SLS) trades at $2.04. The stock has a price-to-earnings ratio of -7.08.

On 2025-12-12, SELLAS Life Sciences(SLS) stock traded between a low of $1.99 and a high of $2.12. Shares are currently priced at $2.04, which is +2.5% above the low and -3.8% below the high.

The SELLAS Life Sciences(SLS)'s current trading volume is 5.73M, compared to an average daily volume of 5.86M.

During the past year, SELLAS Life Sciences(SLS) stock moved between $0.77 at its lowest and $2.48 at its peak.

During the past year, SELLAS Life Sciences(SLS) stock moved between $0.77 at its lowest and $2.48 at its peak.

SLS News

Simply Wall St 23h
SELLAS Life Sciences Is Up 15.5% After Encouraging Phase 2 Data In High-Risk AML

SELLAS Life Sciences Group recently reported Phase 2 data showing that its CDK9 inhibitor SLS009, combined with azacitidine and venetoclax, achieved a 46% overa...

SELLAS Life Sciences Is Up 15.5% After Encouraging Phase 2 Data In High-Risk AML

People also own

Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.